Top Markets
Coin of the day
Hoth Therapeutics, Inc. Hoth Therapeutics, Inc.

Hoth Therapeutics, Inc.

HOTH
Rank in Stocks #32246
Hoth Therapeutics, Inc. engages in the development of new generation therapies... Hoth Therapeutics, Inc. engages in the development of new generation therapies for dermatological disorders. Its product pipeline focuses on potential treatments for indications including atopic dermatitis (also known as eczema), chronic wounds, psoriasis, asthma, and acne. It offers the BioLexa Platform, a drug compound platform for the treatment of eczema. The company was founded by Robbie Knie, Matthew D. Eitner, and James Ahern on May 16, 2017 and is headquartered in New York, NY.
Share Price
$0.8013
Last synced: 2026-08-05
Market Cap
$10.62M
Change (1 day)
0.97%
Change (1 year)
-37.88%
Country
US
Trade Hoth Therapeutics, Inc. (HOTH)

Category

Dividend yield history for Hoth Therapeutics, Inc. (HOTH)
Hoth Therapeutics, Inc. (stock symbol: HOTH) dividend yield (TTM) as of 2026: 0
Average dividend yield, last 5 years : 0.00%
Dividend yield history for Hoth Therapeutics, Inc. (HOTH) from 2026 to 2026
Dividend Yield at the end of each year (TTM)
Year Dividend Yield Change
Not enough data for the provided dates.
Dividend yields (TTM) for similar companies or competitors